Aimia Inc. (TSX:AIM)
Canada · Delayed Price · Currency is CAD 2.750
+0.040 (1.48%)
Aug 27, 2026, 3:59 PM EST
Aimia Employees
Aimia had 2,385 employees as of December 31, 2025. The number of employees increased by 2,367 or 13,150.00% compared to the previous year.
Employees
2,385
Change
2,367
Growth
13,150.00%
Revenue / Employee
211.95K CAD
Profits / Employee
55.05K CAD
Market Cap
239.57M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2,385 | 2,367 | 13,150.00% |
| Dec 31, 2022 | 18 | 0 | - |
| Dec 31, 2021 | 18 | 0 | - |
| Dec 31, 2020 | 18 | -427 | -95.96% |
| Dec 31, 2019 | 445 | -2,455 | -84.66% |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Neo Performance Materials | 1,532 |
| AirBoss of America | 1,204 |
| 5N Plus | 849 |
| Nano One Materials | 104 |
| Tidewater Renewables | 79 |
| EcoSynthetix | 28 |
Aimia News
- 16 days ago - Aimia Q2 Earnings Call Highlights - MarketBeat
- 16 days ago - Aimia Earnings Call Transcript: Q2 2026 - Transcripts
- 16 days ago - Aimia Earnings release: Q2 2026 - Filings
- 16 days ago - Aimia Registration statement: Q2 2026 - Filings
- 16 days ago - Aimia Registration statement: Q2 2026 - Filings
- 16 days ago - Aimia Slides: Q2 2026 - Filings
- 17 days ago - AIM ImmunoTech Releases Q2 2026 Financial Results - AlphaStreet
- 23 days ago - AIM Doses Last Patient Early In Phase 2 DURIPANC For Ampligen In Treating Pancreatic Cancer - Nasdaq